Eli Lilly and Company
Eli Lilly and Company (LLY) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · LLY · as of Sep 30, 2025
Ownership Breakdown
4,044
Institutional Holders
▼ 2 vs Q2
$583.08B
Total Inst. Value
▼ $26.61B vs Q2
941.74M
Shares Outstanding
freeFloat 89.95%
764.80M
13F Shares Held
▼ 18.52M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
LLY largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
LILLY ENDOWMENT INC pharmaceutical preparations | 95.49M | 10.64% | 10.64% | $72.86T | Oct 31, 2025 | ▼ 524.0K |
VANGUARD GROUP INC pharmaceutical preparations | 80.96M | 9.02% | 9.02% | $61.77T | Nov 7, 2025 | ▲ 551.7K |
BLACKROCK, INC. pharmaceutical preparations | 65.81M | 7.33% | 7.33% | $50.21T | Nov 12, 2025 | ▼ 151.9K |
PNC FINANCIAL SERVICES GROUP, INC. pharmaceutical preparations | 51.36M | 5.72% | 5.72% | $39.19T | Nov 7, 2025 | ▲ 70.2K |
STATE STREET CORP pharmaceutical preparations | 34.73M | 3.87% | 3.87% | $26.50T | Nov 14, 2025 | ▲ 219.6K |
CAPITAL RESEARCH GLOBAL INVESTORS pharmaceutical preparations | 25.09M | 2.79% | 2.79% | $19.14T | Nov 13, 2025 | ▲ 4.33M |
FMR LLC pharmaceutical preparations | 24.17M | 2.69% | 2.69% | $18.44T | Nov 13, 2025 | ▼ 1.46M |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 19.82M | 2.21% | 2.21% | $15.07T | Nov 12, 2025 | ▲ 1.69M |
MORGAN STANLEY pharmaceutical preparations | 15.19M | 1.69% | 1.69% | $11.59T | May 27, 2026 | ▲ 317.4K |
CAPITAL WORLD INVESTORS pharmaceutical preparations | 14.97M | 1.67% | 1.67% | $11.42T | Nov 13, 2025 | ▼ 2.66M |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
28
Increased
+15.74M shares0
New Positions
first time holders22
Decreased
−17.58M shares0
Sold Out
fully exitedNet shares change (top 50)
1.83M
+15.74M / −17.58M
Net new holders
+6
0 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
LLY insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
0
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Sulzberger Gabrielle director | May 18, 2026 | Award | 5.018 | $988.09 | $5.0K | 3.0K | Form 4 ↗ |
LUCIANO JUAN R director | May 18, 2026 | Award | 16.109 | $988.09 | $15.9K | 16.9K | Form 4 ↗ |
Fyrwald J Erik director | May 18, 2026 | Award | 10.036 | $988.09 | $9.9K | 75.3K | Form 4 ↗ |
Alvarez Ralph director | May 18, 2026 | Award | 12.566 | $988.09 | $12.4K | 55.6K | Form 4 ↗ |
LILLY ENDOWMENT INC Former 10% Shareholder | May 6, 2026 | Sale | 13,620 | $995.23 | $13.55M | 91.88M | Form 4 ↗ |
LILLY ENDOWMENT INC Former 10% Shareholder | May 6, 2026 | Sale | 2,208 | $996.18 | $2.20M | 91.88M | Form 4 ↗ |
Sulzberger Gabrielle director | Apr 20, 2026 | Award | 5.39 | $919.90 | $5.0K | 3.0K | Form 4 ↗ |
LUCIANO JUAN R director | Apr 20, 2026 | Award | 17.303 | $919.90 | $15.9K | 16.8K | Form 4 ↗ |
Fyrwald J Erik director | Apr 20, 2026 | Award | 10.78 | $919.90 | $9.9K | 75.3K | Form 4 ↗ |
Alvarez Ralph director | Apr 20, 2026 | Award | 13.498 | $919.90 | $12.4K | 55.6K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Eli Lilly and Company (LLY) is primarily owned by institutional investors, who hold approximately 81.2% of total shares outstanding. Company insiders own approximately 10.05%, while retail and public investors account for the remaining 8.74%.
The largest institutional shareholder of Eli Lilly and Company is LILLY ENDOWMENT INC, holding approximately 95.49 million shares — equal to 10.64% of outstanding shares — as of September 30, 2025.
A total of 4,044 institutional investors currently hold LLY stock, with a combined institutional value of approximately $583.08 billion as of the most recent 13F filing period.
Frequently asked questions
LLY ownershipEli Lilly and Company (LLY) is primarily owned by institutional investors, who hold approximately 81.2% of shares. The largest shareholder is LILLY ENDOWMENT INC with a 10.64% stake. Company insiders hold 10.05%. Data sourced from SEC Form 13F as of September 30, 2025.